Ads
related to: novavax vaccine
Search results
Novavax failed to capitalize on fears surrounding mRNA vaccines, activist investor says
Market Watch· 5 days agovaccine-maker’s management, as it called for an overhaul of the company’s marketing strategy to...
Who can get a Covid booster this spring and how can you book?
BBC via Yahoo News· 6 days agoThe most common include a sore arm, headache, chills, fatigue and nausea. They are part of the...
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
Quartz· 4 days agoThe activist hedge fund Shah Capital blasted the leadership of Novavax for not leveraging concerns...
Novavax investor Shah Capital pushes for board shakeup
Reuters via Yahoo News· 5 days ago(Reuters) -A top shareholder of COVID-19 vaccine maker Novavax on Monday said the company has been...
The path to a better Tuberculosis vaccine runs through Montana
The Norman Transcript· 9 hours agoA team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people ...
Novavax (NASDAQ:NVAX) Trading 3.5% Higher
ETF DAILY NEWS· 6 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report)’s stock price traded up 3.5% during mid-day trading on Friday . The stock traded as high as $4.48 and last traded at $4.45. 1,149,644 ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 11 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Hedge fund Shah Capital recommends two new candidates for Novavax board
WSAU Wausau· 5 days ago(Reuters) - U.S.-based hedge fund Shah Capital on Monday recommended the appointment of two new independent directors to the Novavax board. The hedge fund named Suresh Katta ...
Shah Capital proposes new directors for Novavax board By Investing.com
Investing.com· 5 days agoShah Capital, holding a 6.7% stake in vaccine developer Novavax Inc. (NASDAQ: NASDAQ:NVAX), today...
Only One Harm From mRNA COVID Vaccines, Report Determines
MedPage Today· 4 days agoIndependent reviewers confirmed a causal relationship between the first mRNA COVID-19 vaccines and...